06.11.2021
FDA Approves Companion Diagnostic to identify NTRK fusions in solid tumors for Vitrakvi
06.11.2021
EHA: A shorter leukemia therapy? AbbVie, J&J tee up FDA filing for Imbruvica, Venclexta fixed-duration combo aliu Fri, 06/11/2021 - 10:10
06.11.2021
Incyte hits 2nd FDA delay in span of days, this time for atopic dermatitis hopeful ruxolitinib cream esagonowsky Fri, 06/11/2021 - 10:17
06.11.2021
Bayer pledges $300M to boost production in world's 'contraceptive capital’ fkansteiner Fri, 06/11/2021 - 11:06
06.11.2021
Johnson & Johnson told to throw out 60M COVID-19 shots made at troubled Emergent site: report nhigginsdunn Fri, 06/11/2021 - 11:41
06.11.2021
This page lists Recently Issued CBER and Cross-Center Guidance Documents.
06.11.2021
FDA approves nivolumab and ipilimumab for unresectable malignant pleural mesothelioma
06.11.2021
On August 20, 2020, the Food and Drug Administration approved carfilzomib (KYPROLIS, Onyx Pharmaceuticals, Inc.) and daratumumab (DARZALEX, Janssen Biotech, Inc.) in combination with dexamethasone for adult patients with relapsed or refractory multiple myeloma who have received one to three lines o